Dihydrexidine Completed Phase 2 Trials for Schizotypal Personality Disorder / SPD Treatment

Back to Dihydrexidine
IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02507206A D1 Agonist For Working Memory